Online outreach and low-cost testing can encourage relatives of cancer patients to assess their own cancer risk through 'cascade' testing.
Mapping the geography of the immune response in triple negative breast cancers predicts patient survival and sheds light onto new aspects of tumor biology.
Following surgery, the risk of overdose from opioids is highest during the first month. Taking both short- and long-acting opioids also boosts the risk.
A Stanford medicine patient regains quality of life after receiving treatment for his rare inflammatory esophagus condition.
The true driver mutations of cancer are almost always common to all metastases in an individual, according to a Stanford scientist and other researchers.
Scientists have developed an algorithm that combines genome sequence data and electronic health information to predict risk for genetic disease.
A workaround avoids a common, dangerous side effect of gene therapy: an autoimmune reaction to the normal protein, which could improve gene therapy.
In this piece, adapted from Months to Years, mother Giulianna Nenna compares her daughter, who has a brain tumor, to her great-grandmother.
John Farquhar, a beloved mentor, and pioneer in cardiovascular disease prevention at Stanford, died Aug. 22 at the age of 91.
After her older sister died from cancer, 25-year-old Jacqueline Genovese took over care for her children, a 2-year-old and a 4-year-old.
Ketamine, a promising new treatment for depression, works through the brain's opioid system, Stanford study finds, defying long held beliefs.
Ten years and multiple diagnoses later, a young woman finally found answers to her headaches, nausea, and sensory overload at Stanford.
Rania Awaad uses her training in psychiatry and Islamic law to address the health needs of Muslims at Stanford and throughout the Bay Area.
Even substantial efforts in reducing opioid addiction, preventing overdoses and providing addiction treatment won't curb the crisis any time soon.
Although pioneering scientist Gerald Reaven thought that insulin resistance did not affect the kidney, new research suggests that the story is more complex.
The ratio between a certain types of immune cells is able to predict whether latent TB will shift into an active infection, new research has found.